Insider Selling: Hims & Hers Health (NYSE:HIMS) Insider Sells 900 Shares of Stock

Key Points

• Michael Chi, an insider at Hims & Hers Health, sold 900 shares of stock on October 10th for a total value of $52,425, reducing his position by 0.31% to 291,439 shares.
• Hims & Hers Health’s stock experienced a 1.1% decline during trading hours on Tuesday, closing at $54.12, which is significantly lower than its twelve-month high of $72.98.
• The company reported $0.17 earnings per share for the last quarter, missing estimates, while year-over-year revenue increased by 72.6%.

Hims & Hers Health, Inc. (NYSE:HIMS - Get Free Report) insider Michael Chi sold 900 shares of the business's stock in a transaction on Friday, October 10th. The stock was sold at an average price of $58.25, for a total value of $52,425.00. Following the sale, the insider owned 291,439 shares of the company's stock, valued at approximately $16,976,321.75. The trade was a 0.31% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.

Michael Chi also recently made the following trade(s):

• On Wednesday, September 24th, Michael Chi sold 2,100 shares of Hims & Hers Health stock. The shares were sold at an average price of $56.52, for a total value of $118,692.00.
• On Wednesday, September 17th, Michael Chi sold 13,749 shares of Hims & Hers Health stock. The stock was sold at an average price of $50.50, for a total value of $694,324.50.
• On Monday, September 15th, Michael Chi sold 4,150 shares of Hims & Hers Health stock. The shares were sold at an average price of $56.00, for a total value of $232,400.00.
• On Thursday, July 24th, Michael Chi sold 2,100 shares of Hims & Hers Health stock. The stock was sold at an average price of $57.52, for a total value of $120,792.00.
• On Wednesday, July 23rd, Michael Chi sold 13,750 shares of Hims & Hers Health stock. The stock was sold at an average price of $56.00, for a total value of $770,000.00.

Hims & Hers Health Trading Down 1.1%

Hims & Hers Health stock traded down $0.61 during trading hours on Tuesday, reaching $54.12. 21,057,855 shares of the company's stock were exchanged, compared to its average volume of 32,557,629. The firm has a market capitalization of $12.23 billion, a PE ratio of 67.65, a PEG ratio of 3.65 and a beta of 2.25. The company has a quick ratio of 4.46, a current ratio of 4.98 and a debt-to-equity ratio of 1.72. Hims & Hers Health, Inc. has a twelve month low of $18.33 and a twelve month high of $72.98. The firm's 50 day simple moving average is $50.69 and its 200 day simple moving average is $48.29.

Hims & Hers Health (NYSE:HIMS - Get Free Report) last announced its quarterly earnings data on Monday, August 4th. The company reported $0.17 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.18 by ($0.01). The firm had revenue of $544.83 million during the quarter, compared to the consensus estimate of $550.06 million. Hims & Hers Health had a net margin of 9.63% and a return on equity of 26.26%. The company's revenue was up 72.6% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.06 earnings per share. Hims & Hers Health has set its Q3 2025 guidance at EPS. FY 2025 guidance at EPS. Research analysts predict that Hims & Hers Health, Inc. will post 0.29 earnings per share for the current year.

Wall Street Analyst Weigh In

A number of research analysts have recently commented on the stock. Wall Street Zen cut shares of Hims & Hers Health from a "buy" rating to a "hold" rating in a report on Monday, July 28th. Zacks Research cut shares of Hims & Hers Health from a "strong-buy" rating to a "hold" rating in a research report on Tuesday, August 19th. Citigroup reissued a "sell" rating on shares of Hims & Hers Health in a research note on Monday, June 23rd. Needham & Company LLC reissued a "hold" rating on shares of Hims & Hers Health in a report on Tuesday, August 5th. Finally, Canaccord Genuity Group reissued a "buy" rating and issued a $68.00 price objective on shares of Hims & Hers Health in a research note on Friday, September 12th. Two analysts have rated the stock with a Buy rating, nine have issued a Hold rating and three have issued a Sell rating to the stock. According to data from MarketBeat.com, Hims & Hers Health presently has a consensus rating of "Reduce" and an average price target of $38.92.

Institutional Investors Weigh In On Hims & Hers Health

Several institutional investors and hedge funds have recently made changes to their positions in the company. Virtus Advisers LLC acquired a new position in shares of Hims & Hers Health during the second quarter valued at $26,000. Quaker Wealth Management LLC acquired a new position in shares of Hims & Hers Health in the 2nd quarter valued at $29,000. Bessemer Group Inc. boosted its position in shares of Hims & Hers Health by 105.8% in the 2nd quarter. Bessemer Group Inc. now owns 607 shares of the company's stock valued at $30,000 after purchasing an additional 312 shares during the period. Geneos Wealth Management Inc. acquired a new stake in shares of Hims & Hers Health during the first quarter worth approximately $30,000. Finally, Hilltop National Bank purchased a new stake in shares of Hims & Hers Health during the third quarter worth $35,000. 63.52% of the stock is owned by institutional investors and hedge funds.

About Hims & Hers Health

Hims & Hers Health, Inc operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.